Anzeige
Mehr »
Lynx Broker
Login
Sonntag, 20.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AG0F ISIN: SE0006091997 Ticker-Symbol: 1YR 
Berlin
18.10.19
18:46 Uhr
13,600 Euro
-0,140
-1,02 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMMUNOVIA AB Chart 1 Jahr
5-Tage-Chart
IMMUNOVIA AB 5-Tage-Chart

Aktuelle News zur IMMUNOVIA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
Börsennews zur IMMUNOVIA Aktie und weiteren Hot Stocks erhalten
03.05.Immunovia - Optimised hunting for the hidden killer35During 2019, Immunovia will focus on optimising the IMMray PanCan-d test in preparation for the start of a commercial private testing service for pancreatic cancer (PDAC). The sample optimisation study...
► Artikel lesen
26.04.Immunovia - Report from AGM27STOCKHOLM, April 26, 2019 /PRNewswire/ -- The Annual General Meeting (AGM) of Immunovia AB (publ), corporate identity number 556730-4299 was held at Gamla Gästmatsalen in Medicon Village...
► Artikel lesen
24.04.Immunovia Interim Report, January-March 201951STOCKHOLM, April 24, 2019 /PRNewswire/ -- During the first quarter of 2019, we remained focused on our product launch strategy and continued to create value, as we reached several key objectives...
► Artikel lesen
10.04.Corrected: Immunovia and University College of London Sign Agreement to Expand Validation Studies of IMMray PanCan-d for Early Signs and Symptoms27LUND, Sweden, April 10, 2019 /PRNewswire/ -- Immunovia today announced that Prof. Stephen Pereira and his team at the institute for Liver and Digestive Health, University College London (UCL)...
► Artikel lesen
04.03.Immunovia Publishes the Annual Report for the Financial Year 201823LUND, Sweden, March 4, 2019 /PRNewswire/ -- Immunovia has today published the annual report for 2018 in Swedish. It is available on Immunovia's website. Mats Grahn, CEO, comments: "We...
► Artikel lesen
04.03.Immunovia Provides an Update on the Optimization Work to Meet the Expected Performance for Commercialization of IMMray PanCan-d29LUND, SWEDEN, March 4, 2019 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia") today announced an update on the optimization process to refine the algorithms and eliminate any potential variations...
► Artikel lesen
14.02.Immunovia Full Year Report, January-December 201829STOCKHOLM, Feb. 14, 2019 /PRNewswire/ -- Throughout 2018, we continued to build on our mission to develop and validate accurate bloodbased diagnostic tests that can make a real and...
► Artikel lesen
14.02.Immunovia to Participate in Upcoming Investor Conferences in March20LUND, Sweden, Feb. 14, 2019 /PRNewswire/ -- Immunovia AB today announced that Mats Grahn, Chief Executive Officer, will participate and host one-on-one investor meetings at the following...
► Artikel lesen
12.02.Invitation to Presentation of Immunovia's Full Year Report 2018 on February 14, 201923LUND, Sweden, Feb. 12, 2019 /PRNewswire/ -- Immunovia invites to a teleconference (in English) for investors, analysts and media on February 14, at 5:30 - 6:30 p.m. CET. Immunovia will...
► Artikel lesen
12.02.Immunovia AB Announces Appointment of Senior Director of Investor Relations24LUND, Sweden, Feb. 12, 2019 /PRNewswire/ -- (Nasdaq Stockholm: IMMNOV), to strengthen IR and shareholder communication Immunovia today announced that Julie Silber has joined as Director...
► Artikel lesen
13.11.18Immunovia Invited to Present at Jefferies 2018 London Healthcare Conference20LUND, Sweden, Nov. 13, 2018 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), today announced that the Company has been invited to present at the Jefferies 2018 London Healthcare Conference...
► Artikel lesen
07.11.18Immunovia Interim Report January-September 201820STOCKHOLM, Nov. 7, 2018 /PRNewswire/ -- Immunovia's IMMray platform for blood-based biomarker signatures offers exciting new opportunities to develop accurate diagnostic tests that can detect...
► Artikel lesen
06.11.18Immunovia Sponsors Primary Care Educational Symposium at Fenway Park in Honor of World Pancreatic Cancer Day25MARLBOROUGH, Massachusetts, Nov. 6, 2018 /PRNewswire/ -- On November 15, 2018 Immunovia will sponsor a unique educational symposium for primary care clinicians in honor of World Pancreatic...
► Artikel lesen
05.11.18Invitation to Presentation of Immunovia's Interim Report January-September 2018 on November 7, 201829LUND, Sweden, Nov 5, 2018 /PRNewswire/ -- Immunovia will publish the company's interim report for the period January-September 2018 on Wednesday, November 7, at 08:30 a.m. CET. Immunovia...
► Artikel lesen
26.10.18Immunovia AB (Publ) Nomination Committee Appointed for AGM 201918According to the instruction that was adopted at the Immunovia AB (Publ) AGM May 3 2018, the nomination committee should consist of four members LUND, Sweden, Oct. 26, 2018 /PRNewswire/...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1